| Year |
Citation |
Score |
| 2016 |
Borad MJ, Egan JB, Condjella RM, Liang WS, Fonseca R, Ritacca NR, McCullough AE, Barrett MT, Hunt KS, Champion MD, Patel MD, Young SW, Silva AC, Ho TH, Halfdanarson TR, et al. Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced Cancers. Scientific Reports. 6: 25. PMID 28003660 DOI: 10.1038/S41598-016-0021-4 |
0.364 |
|
| 2015 |
Ho TH, Nateras RN, Yan H, Park JG, Jensen S, Borges C, Lee JH, Champion MD, Tibes R, Bryce AH, Carballido EM, Todd MA, Joseph RW, Wong WW, Parker AS, et al. A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona. Plos One. 10: e0132831. PMID 26181416 DOI: 10.1371/Journal.Pone.0132831 |
0.349 |
|
| 2015 |
Ho TH, Park IY, Zhao H, Tong P, Champion MD, Yan H, Monzon FA, Hoang A, Tamboli P, Parker AS, Joseph RW, Qiao W, Dykema K, Tannir NM, Castle EP, et al. High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma. Oncogene. PMID 26073078 DOI: 10.1038/onc.2015.221 |
0.327 |
|
| 2015 |
Zhu YX, Yin H, Bruins LA, Shi CX, Jedlowski P, Aziz M, Sereduk C, Kortuem KM, Schmidt JE, Champion M, Braggio E, Keith Stewart A. RNA interference screening identifies lenalidomide sensitizers in multiple myeloma, including RSK2. Blood. 125: 483-91. PMID 25395420 DOI: 10.1182/blood-2014-05-577130 |
0.318 |
|
| 2015 |
Kortüm KM, Langer C, Monge J, Bruins L, Egan JB, Zhu YX, Shi CX, Jedlowski P, Schmidt J, Ojha J, Bullinger L, Liebisch P, Kull M, Champion MD, Van Wier S, et al. Targeted sequencing using a 47 gene multiple myeloma mutation panel (M(3) P) in -17p high risk disease. British Journal of Haematology. 168: 507-10. PMID 25302557 DOI: 10.1111/bjh.13171 |
0.316 |
|
| 2015 |
Francis P, Alvarez LM, Lenkiewicz E, Champion M, Evers L, Anderson KL, McCullough AE, Barrett MT, Pockaj B. Abstract P2-03-07: Deep clonal profiling identifies distinct mechanisms of heterogeneity and evolution in breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P2-03-07 |
0.35 |
|
| 2015 |
Champion MD, Francis P, Pockaj BA, Barrett MT. Abstract 4861: Hybrid clustering methodologies to distinguish CNAs and/or SNVs that drive subclonal differentiation in samples from a breast cancer patient primary tumor and metastatic lymph nodes Cancer Research. 75: 4861-4861. DOI: 10.1158/1538-7445.Am2015-4861 |
0.351 |
|
| 2014 |
Borad MJ, Champion MD, Egan JB, Liang WS, Fonseca R, Bryce AH, McCullough AE, Barrett MT, Hunt K, Patel MD, Young SW, Collins JM, Silva AC, Condjella RM, Block M, et al. Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma. Plos Genetics. 10: e1004135. PMID 24550739 DOI: 10.1371/Journal.Pgen.1004135 |
0.397 |
|
| 2014 |
Egan JB, Barrett MT, Champion MD, Middha S, Lenkiewicz E, Evers L, Francis P, Schmidt J, Shi CX, Van Wier S, Badar S, Ahmann G, Kortuem KM, Boczek NJ, Fonseca R, et al. Whole genome analyses of a well-differentiated liposarcoma reveals novel SYT1 and DDR2 rearrangements. Plos One. 9: e87113. PMID 24505276 DOI: 10.1371/Journal.Pone.0087113 |
0.43 |
|
| 2014 |
Bryce AH, Borad MJ, Condjella RM, Egan JB, Champion MD, Hunt KS, McWilliams RR, McCullough AE, Kurdoglu A, Aldrich J, Izatt T, Nasser S, Christoforides A, Phillips L, Liang WS, et al. A study of real-time CLIA-enabled whole genome tumor sequencing: Results for testicular cancer and sarcomatoid RCC. Journal of Clinical Oncology. 32: 463-463. DOI: 10.1200/Jco.2014.32.4_Suppl.463 |
0.427 |
|
| 2014 |
Zhu YX, Braggio E, Shi C, Kortüm KM, Bruins LA, Schmidt JE, Chang X, Langlais P, Moulun L, Jedlowski P, LaPlant B, Laumann KM, Fonseca R, Bergsagel PL, Mikhael J, ... ... Champion MD, et al. Ikaros expression levels to predict response and survival following pomalidomide and dexamethasone in multiple myeloma (MM). Journal of Clinical Oncology. 32: 8540-8540. DOI: 10.1200/Jco.2014.32.15_Suppl.8540 |
0.311 |
|
| 2014 |
Kortuem KM, Stewart AK, Bruins LA, Ahmann G, Vasmatzis G, Rajkumar SV, Kumar S, Dispenzieri A, Lacy MQ, Gertz MA, Fonseca R, Champion M, Bergsagel PL, Braggio E. Development and Results of a Multiple Myeloma Specific Custom 77-Gene Mutation Panel for Clinical Targeted Sequencing Blood. 124: 169-169. DOI: 10.1182/Blood.V124.21.169.169 |
0.331 |
|
| 2014 |
Egan JB, Bryce AH, Champion MD, Liang WS, Fonseca R, McCullough AE, Barrett MT, Hunt K, Condjella RM, McWilliams RR, Mastrian SD, LoBello J, Hoff DV, Craig DW, Stewart AK, et al. Abstract 4694: Indices of actionability and clinical utility in a CLIA-enabled study of whole genome/exome/RNA sequencing in 33 cancer patients: Actionable vs. utility Cancer Research. 74: 4694-4694. DOI: 10.1158/1538-7445.Am2014-4694 |
0.389 |
|
| 2013 |
Pearson T, Hornstra HM, Sahl JW, Schaack S, Schupp JM, Beckstrom-Sternberg SM, O'Neill MW, Priestley RA, Champion MD, Beckstrom-Sternberg JS, Kersh GJ, Samuel JE, Massung RF, Keim P. When outgroups fail; phylogenomics of rooting the emerging pathogen, Coxiella burnetii. Systematic Biology. 62: 752-62. PMID 23736103 DOI: 10.1093/Sysbio/Syt038 |
0.321 |
|
| 2013 |
Zhu YX, Bruins L, Shi C, Schmidt J, Sereduk C, Champion M, Braggio E, Yin H, Stewart AK. A Synthetic Lethality Druggable Genome RNAi Screen Identifies Genes Mediating Sensitivity To Lenalidomide In Multiple Myeloma Including RSK2 Blood. 122: 3084-3084. DOI: 10.1182/Blood.V122.21.3084.3084 |
0.365 |
|
| 2013 |
Borad MJ, Egan J, Champion M, Hunt K, McWilliams R, McCullough A, Aldrich J, Nasser S, Liang W, Barrett M, Craig D, Ramanathan R, Carpten J, Stewart AK, Bryce A. Abstract CT112: Implementation of CLIA enabled integrated whole genome (WGS)/exome (WES)/transcriptome (RNAseq) next-gen sequencing to identify therapeutically relevant targets in advanced cancer patients Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-C66 |
0.381 |
|
| 2011 |
Desjardins CA, Champion MD, Holder JW, Muszewska A, Goldberg J, Bailão AM, Brigido MM, Ferreira ME, Garcia AM, Grynberg M, Gujja S, Heiman DI, Henn MR, Kodira CD, León-Narváez H, et al. Comparative genomic analysis of human fungal pathogens causing paracoccidioidomycosis. Plos Genetics. 7: e1002345. PMID 22046142 DOI: 10.1371/Journal.Pgen.1002345 |
0.327 |
|
| 2011 |
Champion MD. Host-pathogen o-methyltransferase similarity and its specific presence in highly virulent strains of Francisella tularensis suggests molecular mimicry. Plos One. 6: e20295. PMID 21637805 DOI: 10.1371/journal.pone.0020295 |
0.334 |
|
| 2009 |
Champion MD, Zeng Q, Nix EB, Nano FE, Keim P, Kodira CD, Borowsky M, Young S, Koehrsen M, Engels R, Pearson M, Howarth C, Larson L, White J, Alvarado L, et al. Comparative genomic characterization of Francisella tularensis strains belonging to low and high virulence subspecies. Plos Pathogens. 5: e1000459. PMID 19478886 DOI: 10.1371/Journal.Ppat.1000459 |
0.317 |
|
| 2003 |
Harris D, Orme C, Kramer J, Namba L, Champion M, Palladino MJ, Natzle J, Hawley RS. A deficiency screen of the major autosomes identifies a gene (matrimony) that is haplo-insufficient for achiasmate segregation in Drosophila oocytes. Genetics. 165: 637-52. PMID 14573476 |
0.476 |
|
| 2002 |
Champion MD, Hawley RS. Playing for half the deck: the molecular biology of meiosis. Nature Cell Biology. 4: s50-6. PMID 12479615 DOI: 10.1038/ncb-nm-fertilityS50 |
0.485 |
|
| Show low-probability matches. |
